• Logo
  • SBMUJournals

Investigation of health benefits of cocoa in human colorectal cancer cell line, HT-29 through interactome analysis

Mona Zamanian Azodi, Mostafa Rezaei-Tavirani




Aim: This bioinformatics study aims to identify the potential key genes influenced by cocoa extraction treatment on colon cancer cell line HT-29 after 24h.

Background: Cocoa consumption has been claimed to have a beneficial effect on cancer.

Methods: The microarray dataset (GSE94154) from GEO, was the source for differentially expressed genes (DEGs) extraction through GEO2R analysis. The comparison was between 3 controls of colorectal cell line HT-29 and 3 ones incubated with cocoa extraction after 24 h. Afterwards, the top significant DEGs were assigned for protein-protein interaction network construction and analysis by Cytoscape v 3.7.0. and the related applications.

Results: The findings indicate that there are 222 up-regulated and 28 down-regulated genes among 250 top-ranked DEGs. What is more, centrality analysis of the DEGs network identified 10 hub-bottlenecks that ISG15, MX 1, and STAT1 were among the significant differential expression genes with the contribution in type 1 interferon signaling pathway, positive regulation of erythrocyte differentiation, and negative regulation of viral genome replication.

Conclusion:  In conclusion, the underlying mechanisms of cocoa treatment could be clarified by its up-regulatory and modulatory effect on prominent genes of tumor suppressor family. In other words, valuable clues for future clinical studies of cocoa health benefits are highlighted in this study once validation studies are carried out. 


: Colon cancer, Cocoa extraction, Transcriptome, Interactome profile, Tumor suppressor genes


Buchwald P, Hall C, Davidson C, Dixon L, Dobbs B, Robinson B, et al. Improved survival for rectal cancer compared to colon cancer: the four cohort study. ANZ journal of surgery. 2018;88(3):E114-E7.

Lacy AM, García-Valdecasas JC, Delgado S, Castells A, Taurá P, Piqué JM, et al. Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial. The Lancet. 2002;359(9325):2224-9.

Dalilan S, Rezaei-Tavirani M, Nabiuni M, Heidari-Keshel S, Azodi MZ, Zali H. Aqueous extract of Lavender angustifolia inhibits lymphocytes proliferation of Hodgkin's lymphoma patients. Iranian journal of cancer prevention. 2013;6(4):201.

Rezaie-Tavirani M, Fayazfar S, Heydari-Keshel S, Rezaee MB, Zamanian-Azodi M, Rezaei-Tavirani M, et al. Effect of essential oil of Rosa Damascena on human colon cancer cell line SW742. Gastroenterology and Hepatology from bed to bench. 2013;6(1):25.

Andújar I, Recio M, Giner R, Ríos J. Cocoa polyphenols and their potential benefits for human health. Oxidative medicine and cellular longevity. 2012;2012.

Martínez-Pinilla E, Oñatibia-Astibia A, Franco R. The relevance of theobromine for the beneficial effects of cocoa consumption. Frontiers in pharmacology. 2015;6:30.

Corti R, Flammer AJ, Hollenberg NK, Lüscher TF. Cocoa and cardiovascular health. Circulation. 2009;119(10):1433-41.

Llorach R, Urpi-Sarda M, Jauregui O, Monagas M, Andres-Lacueva C. An LC-MS-based metabolomics approach for exploring urinary metabolome modifications after cocoa consumption. Journal of proteome research. 2009;8(11):5060-8.

Martín M, Goya L, Ramos S. Preventive effects of cocoa and cocoa antioxidants in colon cancer. Diseases. 2016;4(1):6.

Ramljak D, Romanczyk LJ, Metheny-Barlow LJ, Thompson N, Knezevic V, Galperin M, et al. Pentameric procyanidin from Theobroma cacao selectively inhibits growth of human breast cancer cells. Molecular cancer therapeutics. 2005;4(4):537-46.

Sauceda-Friebe JC, Karsunke XY, Vazac S, Biselli S, Niessner R, Knopp D. Regenerable immuno-biochip for screening ochratoxin A in green coffee extract using an automated microarray chip reader with chemiluminescence detection. Analytica chimica acta. 2011;689(2):234-42.

Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome research. 2003;13(11):2498-504.

Szklarczyk D, Morris JH, Cook H, Kuhn M, Wyder S, Simonovic M, et al. The STRING database in 2017: quality-controlled protein–protein association networks, made broadly accessible. Nucleic acids research. 2016:gkw937.

Assenov Y, Ramírez F, Schelhorn S-E, Lengauer T, Albrecht M. Computing topological parameters of biological networks. Bioinformatics. 2007;24(2):282-4.

Kacprowski T, Doncheva NT, Albrecht M. NetworkPrioritizer: a versatile tool for network-based prioritization of candidate disease genes or other molecules. Bioinformatics. 2013;29(11):1471-3.

Bindea G, Mlecnik B, Hackl H, Charoentong P, Tosolini M, Kirilovsky A, et al. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics. 2009;25(8):1091-3.

Zamanian-Azodi M, Rezaei-Tavirani M, Rostami-Nejad M, Tajik-Rostami F. New Molecular Aspects of Cardiac Arrest; Promoting Cardiopulmonary Resuscitation Approaches. Emergency. 2018;6(1):40.

Hu J-L, Hua Y-J, Chen Y, Yu B, Gao S. Structural analysis of tumor-related single amino acid mutations in human MxA protein. Chinese journal of cancer. 2015;34(3):55.

Mushinski JF, Nguyen P, Stevens LM, Khanna C, Lee S, Chung EJ, et al. Inhibition of tumor cell motility by the interferon-inducible GTPase MxA. Journal of Biological Chemistry. 2009;284(22):15206-14.

Cajee U-F, Hull R, Ntwasa M. Modification by ubiquitin-like proteins: significance in apoptosis and autophagy pathways. International journal of molecular sciences. 2012;13(9):11804-31.

Yeung T-L, Tsai C, Leung C, Au Yeung C-L, Thompson M, Lu K, et al. ISG15 Promotes ERK1 ISGylation, CD8+ T Cell Activation and Suppresses Ovarian Cancer Progression. Cancers. 2018;10(12):464.

Zuo C, Sheng X, Min Ma MX, Ouyang L. ISG15 in the tumorigenesis and treatment of cancer: An emerging role in malignancies of the digestive system. Oncotarget. 2016;7(45):74393.

Kaler P, Owusu BY, Augenlicht L, Klampfer L. The role of STAT1 for crosstalk between fibroblasts and colon cancer cells. Frontiers in oncology. 2014;4:88.

Di Franco S, Turdo A, Todaro M, Stassi G. Role of type I and II interferons in colorectal cancer and melanoma. Frontiers in immunology. 2017;8:878.

DOI: https://doi.org/10.22037/ghfbb.v0i0.1557